Due to its ubiquitous nature, MCM2 is less likely to be considered on its own as a sensitive diagnostic marker for cervical cancer but shows a certain degree of promise as a concatenated detection method along with HPV typing, p16 or Ki-67 biomarkers (Zheng, 2015; Liao et al., 2018). Here, CDKN2A is linked to cervical cancer.